MX174145B - Procedimiento para la preparacion de una sal formada por ranitidina y un complejo de bismuto con un acido carboxilico - Google Patents

Procedimiento para la preparacion de una sal formada por ranitidina y un complejo de bismuto con un acido carboxilico

Info

Publication number
MX174145B
MX174145B MX1682989A MX1682989A MX174145B MX 174145 B MX174145 B MX 174145B MX 1682989 A MX1682989 A MX 1682989A MX 1682989 A MX1682989 A MX 1682989A MX 174145 B MX174145 B MX 174145B
Authority
MX
Mexico
Prior art keywords
bismute
ranitidine
complex
procedure
preparation
Prior art date
Application number
MX1682989A
Other languages
English (en)
Spanish (es)
Other versions
MX16829A (es
Inventor
Jhon Watson Clitherow
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888817098A external-priority patent/GB8817098D0/en
Priority claimed from GB898904686A external-priority patent/GB8904686D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MX16829A publication Critical patent/MX16829A/es
Publication of MX174145B publication Critical patent/MX174145B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
MX1682989A 1988-07-18 1989-07-17 Procedimiento para la preparacion de una sal formada por ranitidina y un complejo de bismuto con un acido carboxilico MX174145B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888817098A GB8817098D0 (en) 1988-07-18 1988-07-18 Chemical compounds
GB898904686A GB8904686D0 (en) 1989-03-01 1989-03-01 Chemical compounds

Publications (2)

Publication Number Publication Date
MX16829A MX16829A (es) 1993-10-01
MX174145B true MX174145B (es) 1994-04-25

Family

ID=26294175

Family Applications (1)

Application Number Title Priority Date Filing Date
MX1682989A MX174145B (es) 1988-07-18 1989-07-17 Procedimiento para la preparacion de una sal formada por ranitidina y un complejo de bismuto con un acido carboxilico

Country Status (35)

Country Link
US (1) US5008256A (it)
JP (1) JP2523185B2 (it)
KR (1) KR0122598B1 (it)
CN (1) CN1022626C (it)
AT (1) AT398200B (it)
AU (1) AU632052B2 (it)
BE (1) BE1003254A5 (it)
CA (1) CA1332610C (it)
CH (1) CH679582A5 (it)
CY (1) CY1650A (it)
DE (1) DE3923638C2 (it)
DK (1) DK168381B1 (it)
EG (1) EG19368A (it)
ES (1) ES2014175A6 (it)
FI (1) FI90538C (it)
FR (1) FR2634122B1 (it)
GB (1) GB2220937B (it)
GR (1) GR1000431B (it)
HK (1) HK61392A (it)
HU (2) HU206104B (it)
IE (1) IE61076B1 (it)
IL (1) IL91005A (it)
IT (1) IT1231481B (it)
LU (2) LU87557A1 (it)
MX (1) MX174145B (it)
MY (1) MY104055A (it)
NL (2) NL192604C (it)
NO (2) NO176319C (it)
NZ (1) NZ229958A (it)
PL (1) PL162391B1 (it)
PT (1) PT91188B (it)
SE (1) SE468715B (it)
SG (1) SG51992G (it)
YU (1) YU47021B (it)
ZW (1) ZW8689A1 (it)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0282132B1 (en) * 1987-03-09 1992-09-30 The Procter & Gamble Company Compositions and their use for treating gastrointestinal disorders
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
AU641903B2 (en) * 1988-10-26 1993-10-07 Glaxo Group Limited Carboxylic acid derivatives
GB9004328D0 (en) * 1990-02-27 1990-04-25 Glaxo Group Ltd Chemical compounds
GB9009240D0 (en) * 1990-04-25 1990-06-20 Glaxo Group Ltd Chemical compounds
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds
IE65964B1 (en) * 1990-07-20 1996-01-24 Slagel David Products and processes for the treatment of the alimentary canal
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
ES2130152T3 (es) * 1991-12-06 1999-07-01 Glaxo Group Ltd Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
WO1996019232A1 (en) * 1994-12-19 1996-06-27 Lauteral Limited Combinations of ranitidine hydrochloride-form 1 and bismuth compounds
DE69620582T2 (de) * 1995-01-26 2002-11-07 Nycomed Imaging As, Oslo Verwendung von WISMUTVERBINDUNGEN zur Herstellung eines Arzneimittels zur Behandlung von Magenverstimmungen, die durch Helicobacter pylori verursacht werden
GB9501560D0 (en) 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
EP1035192A1 (de) * 1999-01-26 2000-09-13 Stefan Graichen Additiv für einen Kühlschmierstoff
CN1102585C (zh) * 1999-04-28 2003-03-05 常州兰陵制药有限公司 雷尼替丁枸橼酸铋盐的制备方法
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
CN100402514C (zh) * 2006-08-01 2008-07-16 丽珠医药集团股份有限公司 一种制备枸橼酸铋雷尼替丁的方法
AU2007216671B2 (en) * 2007-07-09 2009-07-16 Cypress Pharmaceutical, Inc. Pleasant-tasting ranitidine formulation
CN102408398B (zh) * 2011-09-20 2012-12-05 江苏汉斯通药业有限公司 枸橼酸铋雷尼替丁的制备方法
US9731999B2 (en) 2011-09-23 2017-08-15 Iqbal Gill Chemical admixtures for hydraulic cements
ES2426539B1 (es) * 2012-04-18 2014-09-09 Dr Healthcare España, S. L. Uso de la diaminooxidasa para el tratamiento o la prevención del trastorno por deficit de atencion con hiperactividad (adhd)
CN103896888B (zh) * 2014-03-28 2015-11-18 常州兰陵制药有限公司 枸橼酸铋雷尼替丁的制备方法
WO2015155297A1 (en) 2014-04-11 2015-10-15 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical combinations of dabigatran and h2-receptor antagonists
WO2015169957A1 (en) 2014-05-09 2015-11-12 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical combinations of rivaroxaban and h2-receptor antagonists
CN107382921A (zh) * 2017-07-28 2017-11-24 常州兰陵制药有限公司 制备枸橼酸铋雷尼替丁的方法
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
FR2531706A1 (fr) * 1982-08-13 1984-02-17 Sanofi Sa Benzamides, leurs sels, procede pour leur preparation et compositions pharmaceutiques les renfermant
BE905235A (fr) * 1986-08-05 1986-12-01 Hasunor Ag Ascorbates antagonistes des recepteurs h2 et leur procede de preparation.
IT1215325B (it) * 1987-01-07 1990-02-08 Barisintex Sa Composti antagonisti di recettori -h2 e procedimento per la loro preparazione.
EP0282132B1 (en) * 1987-03-09 1992-09-30 The Procter & Gamble Company Compositions and their use for treating gastrointestinal disorders
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
DE3710462A1 (de) * 1987-03-30 1988-10-13 Heumann Pharma Gmbh & Co Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes
GB9004328D0 (en) * 1990-02-27 1990-04-25 Glaxo Group Ltd Chemical compounds
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
NZ229958A (en) 1991-09-25
SE8902550D0 (sv) 1989-07-17
ES2014175A6 (es) 1990-06-16
FI893448A (fi) 1990-01-19
GB8916288D0 (en) 1989-08-31
AU632052B2 (en) 1992-12-17
HU206104B (en) 1992-08-28
GB2220937B (en) 1991-11-27
KR910002826A (ko) 1991-02-26
FR2634122A1 (fr) 1990-01-19
SE468715B (sv) 1993-03-08
HU211173A9 (en) 1995-11-28
KR0122598B1 (ko) 1997-11-13
YU47021B (sh) 1994-11-15
NO892936L (no) 1990-01-19
NL8901840A (nl) 1990-02-16
LU88722I2 (fr) 1996-08-23
MX16829A (es) 1993-10-01
NL970046I1 (nl) 1998-03-02
NO892936D0 (no) 1989-07-17
HUT52082A (en) 1990-06-28
IE892309L (en) 1990-01-18
MY104055A (en) 1993-10-30
NL970046I2 (nl) 1998-04-01
EG19368A (en) 1995-02-28
DE3923638C2 (de) 1995-11-23
NO1998007I1 (no) 1998-02-05
PT91188A (pt) 1990-02-08
NO176319C (no) 1995-03-15
IL91005A (en) 1994-10-07
PT91188B (pt) 1995-03-01
LU87557A1 (fr) 1990-07-24
BE1003254A5 (fr) 1992-02-11
FR2634122B1 (fr) 1993-11-19
CA1332610C (en) 1994-10-18
NL192604C (nl) 1997-11-04
JPH02117684A (ja) 1990-05-02
NL192604B (nl) 1997-07-01
DK351789D0 (da) 1989-07-17
AU3817889A (en) 1990-01-18
DE3923638A1 (de) 1990-03-01
ZW8689A1 (en) 1990-02-21
CN1022626C (zh) 1993-11-03
ATA172889A (de) 1994-02-15
PL162391B1 (pl) 1993-10-30
CH679582A5 (it) 1992-03-13
FI893448A0 (fi) 1989-07-17
FI90538B (fi) 1993-11-15
AT398200B (de) 1994-10-25
YU142789A (en) 1991-04-30
CY1650A (en) 1992-12-11
JP2523185B2 (ja) 1996-08-07
IT1231481B (it) 1991-12-07
SE8902550L (sv) 1990-01-19
US5008256A (en) 1991-04-16
GR890100454A (en) 1990-06-27
NO176319B (no) 1994-12-05
DK168381B1 (da) 1994-03-21
GR1000431B (el) 1992-07-30
IL91005A0 (en) 1990-02-09
SG51992G (en) 1992-07-24
IE61076B1 (en) 1994-09-21
DK351789A (da) 1990-01-19
HK61392A (en) 1992-08-21
GB2220937A (en) 1990-01-24
IT8948196A0 (it) 1989-07-17
CN1039419A (zh) 1990-02-07
FI90538C (fi) 1994-02-25

Similar Documents

Publication Publication Date Title
MX174145B (es) Procedimiento para la preparacion de una sal formada por ranitidina y un complejo de bismuto con un acido carboxilico
ES553714A0 (es) Procedimiento para la preparacion de una composicion que contiene una sal de acido hialuronico.
MX162553A (es) Procedimiento para la preparacion de esteres de acido citrico
ES521728A0 (es) Un procedimiento para la preparacion de una sal de adicion de un acido bencenosulfonico de la sultamicilina.
ES544439A0 (es) Procedimiento para la preparacion de acidos a,w -dicarboxi- licos
ES555673A0 (es) Procedimiento para preparar monoamidas de acido difenico.
MX165149B (es) Proceso para la preparacion de un monohidrato cristalino o un monohidrato de la sal de sodio cristalino y producto resultante
PT88974A (pt) Processo para a preparacao de microcapsulas biodegradaveis de peptideos e de proteinas soluveis em agua
ES534509A0 (es) Un procedimiento para la preparacion de acidos fenilquinolin-carboxilicos.
ES535625A0 (es) Un procedimiento para la preparacion de 9-deoxo-9a-metil-9a-aza-9a-homoeritromicina d o una sal de la misma
ES552935A0 (es) Procedimiento para la produccion de d-l-amino acidos
PT88365A (pt) Processo para a preparacao de acidos 2-fenil-4-quinolino-carboxilicos substituidos
PT88260A (pt) Processo para a preparacao de derivados de imidazopiridazina com actividade citotoxica
ES549598A0 (es) Procedimiento para la preparacion de sales de la 5'-metil- tio-5'-deoxiadenosina con acidos sulfonicos de cadena alqui-lica larga
IT8667632A0 (it) Composti dell acido 3alchilcarbamoi lossimetil 3 cefem 4 carbossilico procedimento per la preparazione ditali composti e preparato antibatterico che li contiene
BR8701100A (pt) Processo continuo para a preparacao de um sal pesticidamente ativo
PT88990A (pt) Processo para a preparacao de novos acidos aza-cicloalquil-alcano-difosfonicos
MX14287A (es) Procedimiento para preparar acidos oxoftalazinil-aceticos heterociclicos
IT8448879A1 (it) Preparato esterno a base di acido pantetein - s- solfonico o suoi sali per applicazione sulla pelle
ES555835A0 (es) Un procedimiento para la produccion de una isatina y una sal de la misma
ES550809A0 (es) Procedimiento de preparacion de un tioeter basico y de su sal
ES549853A0 (es) Un procedimiento para la preparacion de anilidas de acidos arilaceticos sustituidos.
BR8603987A (pt) Processo para a preparacao de um derivado de quinaldinamida e para a preparacao de um sal de adicao de acido do derivado de quinaldinamida
ES529565A0 (es) Procedimiento de preparacion de eteres oximas basicos, y de sus sales de adicion acidas farmaceuticamente aceptables
PT89108A (pt) Processo para a preparacao de acidos fenoxi-propanoicos substituidos